지역사회 상처 관리 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the community wound care market size was valued at USD 6.36 billion in 2025 and is estimated to grow from USD 6.84 billion in 2026 to reach USD 9.83 billion by 2031, at a CAGR of 7.51% during the forecast period (2026-2031).

This report is Segmented by Service Type (Home Health, Community Nursing, and More), Product Type (Advanced Dressings, Traditional Products, and More), Wound Type (Chronic, Acute), End User (Home Care Agencies, Hospitals, and More), Distribution (Direct Tenders, Retail/Pharmacy, Online/ECommerce, Distributors, Others), and Geography (North America, Europe, Asia-Pacific, and More). Forecasts are in Value (USD).

Global Community Wound Care Market Trends and Insights

Rising Chronic Wound Burden in Home and Post-Acute Settings

Diabetes and vascular disease are expanding the patient base that needs wound care outside hospital settings. In 2025, 53.1 million Americans had diabetes, and 15.00%-34.00% of people with diabetes develop a diabetic foot ulcer over their lifetime, which keeps a steady flow of patients moving into the community wound care market. Chronic wounds affect up to 2.50% of the population in developed countries, which supports recurring demand for dressings, professional visits, and telehealth-enabled monitoring in the community wound care market.

Pressure injuries affect 5.00% of patients receiving community nursing care, and that share rises in long-term care settings where repositioning resources are limited. Chronic wound demand is less exposed to short-term economic swings because healing often requires serial assessment, repeated consumable use, and extended follow-up. This leaves the community wound care market supported by disease patterns that remain embedded across aging and diabetic populations.

Shift of Wound Care Delivery from Hospitals to Community Sites

Payment reform and hospital capacity pressure are moving more wound care into home and community settings. CMS updated the Home Health Prospective Payment System for CY 2026, including changes to 30-day episode rates and case-mix weights that better reflect complex wound presentations managed at home. A 2026 study in the British Journal of Community Nursing reported that community nurses are handling a growing share of patients with multimorbidities whose wounds need interventions once associated with specialist outpatient settings. The shift is raising the clinical intensity of wound care episodes that sit within the community wound care market, which also raises the value of structured protocols and consistent assessment tools. Agencies that rely on unstructured clinical judgment alone are more exposed to variability in healing progression and workload. Agencies that standardize workflows are better placed to turn this care transfer into an advantage within the community wound care market.

High Per-Episode Cost of Advanced Dressings and Biologics

The cost of advanced dressings and biologics remains a practical limit on how far premium wound care can spread in community settings. Reimbursement pressure increased when only 18 skin substitute products were confirmed as covered under newly finalized Local Coverage Determinations effective January 1, 2026, which narrowed the commercially protected field around Medicare-supported products in the community wound care market. Coloplast later reported a DKK 3.00 billion (USD 0.45 billion) impairment loss, and linked a weaker recovery in U.S. outpatient wound care to the Medicare reimbursement overhaul affecting skin substitutes. These changes mean premium products need stronger economic justification when community providers operate inside tighter episode payments. Manufacturers can no longer depend on broad premium positioning if coverage is selective and provider margins are compressed. This creates near-term caution around category mix and product adoption in the community wound care market.

Other drivers and restraints analyzed in the detailed report include:

1. Greater Use of Portable Advanced Wound Therapy in Home Care
2. AI-Assisted Wound Documentation Improving Nurse Productivity
3. Community Workforce Shortages and Variable Wound Expertise

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Home Health Wound Care held 34.22% of revenue in 2025, which made it the largest service segment in the community wound care market. That lead reflects the practical value of clinician-led in-home visits for patients who need repeated dressing changes and close wound follow-up. The service also fits the broader shift away from hospital-centered care, as more complex patients are discharged earlier into structured home episodes. CMS policy updates are reinforcing that direction by improving the payment visibility around home-based wound episodes. Outpatient Wound Clinics remain the next layer for patients whose wound complexity exceeds what one visit at home can safely support.

Community Nursing and District Nursing are projected to grow at 8.53% CAGR through 2031, which makes it the fastest-growing service category within the community wound care market. Germany strengthened this pathway in December 2025 when the G-BA amended the HKP-RL to prioritize chronic and hard-to-heal wound care in home settings using specialized providers. That change expands the addressable base for local nursing services and supports earlier referral away from hospital-led pathways. Long-Term Care and Skilled Nursing Facilities continue to serve older adults whose mobility limits and chronic wound exposure create recurring care demand. The community wound care industry is therefore moving toward more formalized local care pathways, especially where nursing infrastructure and reimbursement rules already support home-first delivery.

Advanced Wound Dressings accounted for 52.19% of the community wound care market size in 2025, which kept them firmly in the lead among product categories. Their position reflects long clinical familiarity, broad payer acceptance, and easy integration into agency and distributor supply chains. Foam, hydrocolloid, and antimicrobial dressings remain core formulary items because they fit a wide range of chronic wound needs during routine community visits. Smith+Nephew reinforced this category in May 2026 with ALLEVYN COMPLETE CARE, a 5-layer foam dressing positioned for chronic wound use in home and community settings. Traditional Wound Care Products still serve lower-complexity acute wounds where cost and ease of use remain important buying factors.

Biologics and Skin Substitutes are projected to grow at 9.17% CAGR through 2031, which places them ahead of every other product segment in the community wound care market. The growth reflects a stronger clinical focus on placental allografts, fish-skin grafts, and related tissue-based options for difficult diabetic foot ulcers and other slow-healing wounds. Wound Therapy Devices also hold an important premium position, especially as portable negative pressure systems make complex wound management more practical at home. The January 2026 reimbursement reset means premium biologics now face more direct scrutiny around coverage and value. That leaves the community wound care market favoring suppliers that can pair strong healing outcomes with more defensible economic positioning.

Complete Report Scope:

• By Service Type
  • Home Health Wound Care
  • Community Nursing and District Nursing
  • Outpatient Wound Clinics
  • Long-Term Care and Skilled Nursing Facilities
  • Others
• By Product Type
  • Advanced Wound Dressings
  • Traditional Wound Care Products
  • Wound Therapy Devices
  • Biologics and Skin Substitutes
  • Others
• By Wound Type
  • Chronic Wounds
    • Diabetic Foot Ulcers
    • Venous Leg Ulcers
    • Pressure Injuries
    • Other Chronic Wounds
  • Acute Wounds
    • Surgical Wounds
    • Traumatic Wounds
    • Other Acute Wounds
• By End User
  • Home Care Agencies
  • Hospitals and Clinics
  • Long-Term Care Facilities
  • Ambulatory and Specialized Wound Centers
  • Others
• By Distribution Channel
  • Direct Tenders and Institutional Supply
  • Retail and Pharmacy Channels
  • Online and eCommerce
  • Medical Supply Distributors
  • Others
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America held 33.50% of the community wound care market share in 2025, which made it the largest regional base. The United States anchors that position because Medicare home health policy gives providers a defined payment structure for community wound episodes. The CY 2026 rate update set disposable NPWT payment at USD 282.10 per applicable device and updated home health episode rates by 2%, which improves visibility for agencies managing more complex wound caseloads. That clarity supports broader use of advanced wound management in the home and strengthens post-acute continuity within the community wound care market. The January 2026 Medicare skin substitute overhaul also changed competitive conditions by favoring categories and products with clearer reimbursement footing.

Europe remains a major pillar of the community wound care market because district nursing is already built into several health systems. Germany reinforced this model in December 2025 when the G-BA amended the HKP-RL to prioritize chronic and hard-to-heal wounds in home settings through specialized providers. That rule directly expands the reimbursable base for home wound visits under statutory health insurance and gives community providers a stronger position in the care pathway. The United Kingdom continues to face district nurse pressure, and recent nursing literature linked staffing levels and wound expertise directly to wound management consistency and outcomes. These conditions favor suppliers and care partners that can simplify protocols, standardize documentation, and reduce variability within the community wound care market.

Asia-Pacific is projected to grow at 7.21% CAGR through 2031, which makes it the fastest-growing regional part of the community wound care market size. China and India are the primary volume drivers because both combine large diabetic populations with wider community and primary care expansion. The region also benefits from policy direction that supports chronic disease management and community health capacity, which gives wound services a broader base for scale. Japan adds steady demand because its older population structure sustains long-term care and district nursing needs, especially for pressure injury management. The Middle East and Africa remain smaller in scale, but Gulf health systems are widening home health programs as part of broader care delivery diversification. South America is led by Brazil, where public community care structures support wound management, although product access and specialist training gaps still limit faster adoption of advanced wound care.

1. Advanced Medical Solutions Group
2. B. Braun
3. Cardinal Health
4. Coloplast
5. Convatec
6. Essity
7. Hollister
8. Integra LifeSciences
9. Integra LifeSciences
10. Kerecis
11. Medline Industries
12. Medtronic
13. MIMEDX Group
14. Molnlycke Health Care
15. Organogenesis
16. Hartmann Group
17. Smiths Group
18. Solventum
19. URGO Medical

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising chronic wound burden in home and post-acute settings
  • 4.2.2 Shift of wound care delivery from hospitals to community sites
  • 4.2.3 Greater use of portable advanced wound therapy in home care
  • 4.2.4 Better reimbursement visibility for outpatient and home health wound episodes
  • 4.2.5 AI-assisted wound documentation improving nurse productivity
  • 4.2.6 Care pathway standardization in community nursing networks
• 4.3 Market Restraints
  • 4.3.1 High per-episode cost of advanced dressings and biologics
  • 4.3.2 Uneven coverage rules across payers and care settings
  • 4.3.3 Community workforce shortages and variable wound expertise
  • 4.3.4 Documentation and coding burden for home-based wound claims
• 4.4 Value Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces Analysis
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Suppliers
  • 4.7.3 Bargaining Power of Buyers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Intensity of Competitive Rivalry

5 Market Size & Growth Forecasts (Value, USD)

• 5.1 By Service Type
  • 5.1.1 Home Health Wound Care
  • 5.1.2 Community Nursing and District Nursing
  • 5.1.3 Outpatient Wound Clinics
  • 5.1.4 Long-Term Care and Skilled Nursing Facilities
  • 5.1.5 Others
• 5.2 By Product Type
  • 5.2.1 Advanced Wound Dressings
  • 5.2.2 Traditional Wound Care Products
  • 5.2.3 Wound Therapy Devices
  • 5.2.4 Biologics and Skin Substitutes
  • 5.2.5 Others
• 5.3 By Wound Type
  • 5.3.1 Chronic Wounds
    • 5.3.1.1 Diabetic Foot Ulcers
    • 5.3.1.2 Venous Leg Ulcers
    • 5.3.1.3 Pressure Injuries
    • 5.3.1.4 Other Chronic Wounds
  • 5.3.2 Acute Wounds
    • 5.3.2.1 Surgical Wounds
    • 5.3.2.2 Traumatic Wounds
    • 5.3.2.3 Other Acute Wounds
• 5.4 By End User
  • 5.4.1 Home Care Agencies
  • 5.4.2 Hospitals and Clinics
  • 5.4.3 Long-Term Care Facilities
  • 5.4.4 Ambulatory and Specialized Wound Centers
  • 5.4.5 Others
• 5.5 By Distribution Channel
  • 5.5.1 Direct Tenders and Institutional Supply
  • 5.5.2 Retail and Pharmacy Channels
  • 5.5.3 Online and eCommerce
  • 5.5.4 Medical Supply Distributors
  • 5.5.5 Others
• 5.6 By Geography
  • 5.6.1 North America
    • 5.6.1.1 United States
    • 5.6.1.2 Canada
    • 5.6.1.3 Mexico
  • 5.6.2 Europe
    • 5.6.2.1 Germany
    • 5.6.2.2 United Kingdom
    • 5.6.2.3 France
    • 5.6.2.4 Italy
    • 5.6.2.5 Spain
    • 5.6.2.6 Rest of Europe
  • 5.6.3 Asia-Pacific
    • 5.6.3.1 China
    • 5.6.3.2 Japan
    • 5.6.3.3 India
    • 5.6.3.4 Australia
    • 5.6.3.5 South Korea
    • 5.6.3.6 Rest of Asia-Pacific
  • 5.6.4 Middle East and Africa
    • 5.6.4.1 GCC
    • 5.6.4.2 South Africa
    • 5.6.4.3 Rest of Middle East and Africa
  • 5.6.5 South America
    • 5.6.5.1 Brazil
    • 5.6.5.2 Argentina
    • 5.6.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global Level Overview, Market Level Overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share, Products and Services, Recent Developments)
  • 6.3.1 Advanced Medical Solutions Group plc
  • 6.3.2 B. Braun SE
  • 6.3.3 Cardinal Health, Inc.
  • 6.3.4 Coloplast A/S
  • 6.3.5 ConvaTec Group PLC
  • 6.3.6 Essity AB
  • 6.3.7 Hollister Incorporated
  • 6.3.8 Integra LifeSciences Corporation
  • 6.3.9 Integra LifeSciences Holdings Corporation
  • 6.3.10 Kerecis
  • 6.3.11 Medline Industries, LP
  • 6.3.12 Medtronic plc
  • 6.3.13 MiMedx Group, Inc.
  • 6.3.14 Molnlycke Health Care AB
  • 6.3.15 Organogenesis Holdings Inc.
  • 6.3.16 Paul Hartmann AG
  • 6.3.17 Smith+Nephew
  • 6.3.18 Solventum
  • 6.3.19 URGO Medical

7 Market Opportunities & Future Outlook

• 7.1 White-Space and Unmet-Need Assessment